Long-term outcome of capsule endoscopy in obscure gastrointestinal bleeding: a nationwide analysis

Background and study aims: The clinical impact of video capsule endoscopy (VCE) in patients with obscure gastrointestinal bleeding (OGIB) remains undetermined. The aim of this study was to evaluate the long-term clinical impact of VCE in patients with OGIB using a nationwide registry.

Patients and methods: Data from 305 patients who underwent VCE for OGIB from 13 hospitals in Korea between January 2006 and March 2009 were analyzed. Prospectively collected VCE registry data were reviewed, and follow-up data were collected by chart review and telephone interviews with patients. Multivariate regression analyses using hazard ratios (HR) were performed to determine risk factors for rebleeding.

Results: Significant findings were detected in 157 patients (51.5 %). After VCE, interventional treatment was performed in 36 patients (11.8 %). The overall rebleeding rate was 19.0 % during a mean (± SD) follow-up of 38.7 ± 26.4 months. Rebleeding rate did not differ by positive VCE results or application of interventional treatment. Multivariate analysis revealed that angiodysplasia (HR 1.82; 95 % confidence interval [CI] 1.04 – 3.20; P = 0.037) and duration of OGIB > 3 months (HR 1.64; 95 %CI 1.10 – 2.46; P = 0.016) were independent prognostic factors associated with rebleeding. In a subgroup analysis of patients taking anticoagulants, patients who discontinued drugs after VCE showed a lower rebleeding rate than those who did not discontinue this therapy (P = 0.019).

Conclusions: VCE did not have a significant impact on the long-term outcome of patients with OGIB. Patients with angiodysplasia on VCE or OGIB > 3 months need to be closely followed even after interventional treatment. In patients who are taking anticoagulants, discontinuation of drugs is necessary in order to lower the risk of rebleeding.

^* These authors contributed equally to this work.

• References

• 1 Raju GS, Gerson L, Das A et al. American Gastroenterological Association (AGA) Institute technical review on obscure gastrointestinal bleeding. Gastroenterology 2007; 1697-1717
• 2 Pennazio M, Eisen G, Goldfarb N. ICCE consensus for obscure gastrointestinal bleeding. Endoscopy 2005; 1046-1050
• 3 Lin S, Rockey DC. Obscure gastrointestinal bleeding. Gastroenterol Clin North Am 2005; 679-698
• 4 Tang SJ, Haber GB. Capsule endoscopy in obscure gastrointestinal bleeding. Gastrointest Endosc Clin N Am 2004; 87-100
• 5 Mishkin DS, Chuttani R, Croffie J et al. ASGE Technology Status Evaluation Report: wireless capsule endoscopy. Gastrointest Endosc 2006; 539-545
• 6 Triester SL, Leighton JA, Leontiadis GI et al. A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with obscure gastrointestinal bleeding. Am J Gastroenterol 2005; 100: 2407-2418
• 7 Leighton JA, Triester SL, Sharma VK. Capsule endoscopy: a meta-analysis for use with obscure gastrointestinal bleeding and Crohn’s disease. Gastrointest Endosc Clin N Am 2006; 16: 229-250
• 8 Ell C, Remke S, May A et al. The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy 2002; 34: 685-689
• 9 Voderholzer WA, Ortner M, Rogalla P et al. Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis. Endoscopy 2003; 35: 1009-1014
• 10 Costamagna G, Shah SK, Riccioni ME et al. A prospective trial comparing small bowel radiographs and video capsule endoscopy for suspected small bowel disease. Gastroenterology 2002; 123: 999-1005
• 11 Hara AK, Leighton JA, Sharma VK et al. Small bowel: preliminary comparison of capsule endoscopy with barium study and CT. Radiology 2004; 230: 260-265
• 12 Concha R, Amaro R, Barkin JS. Obscure gastrointestinal bleeding: diagnostic and therapeutic approach. J Clin Gastroenterol 2007; 41: 242-251
• 13 Mylonaki M, Fritscher-Ravens A, Swain P. Wireless capsule endoscopy: a comparison with push enteroscopy in patients with gastroscopy and colonoscopy negative gastrointestinal bleeding. Gut 2003; 52: 1122-1126
• 14 Mata A, Bordas JM, Feu F et al. Wireless capsule endoscopy in patients with obscure gastrointestinal bleeding: a comparative study with push enteroscopy. Aliment Pharmacol Ther 2004; 20: 189-194
• 15 Rastogi A, Schoen RE, Slivka A. Diagnostic yield and clinical outcomes of capsule endoscopy. Gastrointest Endosc 2004; 60: 959-964
• 16 Calabrese C, Liguori G, Gionchetti P et al. Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. Intern Emerg Med 2011 DOI: 10.1007/s11739-011-0699-z
• 17 Iwamoto J, Mizokami Y, Shimokobe K et al. The clinical outcome of capsule endoscopy in patients with obscure gastrointestinal bleeding. Hepatogastroenterology 2011; 58: 301-305
• 18 Goenka MK, Majumder S, Kumar S et al. Single center experience of capsule endoscopy in patients with obscure gastrointestinal bleeding. World J Gastroenterol 2011; 17: 774-778
• 19 Zhang BL, Fang YH, Chen CX et al. Single-center experience of 309 consecutive patients with obscure gastrointestinal bleeding. World J Gastroenterol 2009; 15: 5740-5745
• 20 Carey EJ, Leighton JA, Heigh RI et al. A single-center experience of 260 consecutive patients undergoing capsule endoscopy for obscure gastrointestinal bleeding. Am J Gastroenterol 2007; 102: 89-95
• 21 Pennazio M, Santucci R, Rondonotti E et al. Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of 100 consecutive cases. Gastroenterology 2004; 126: 643-653
• 22 Delvaux M, Fassler I, Gay G. Clinical usefulness of the endoscopic video capsule as the initial intestinal investigation in patients with obscure digestive bleeding: validation of a diagnostic strategy based on the patient outcome after 12 months. Endoscopy 2004; 36: 1067-1073
• 23 Saurin JC, Delvaux M, Vahedi K et al. Clinical impact of capsule endoscopy compared to push enteroscopy: 1-year follow-up study. Endoscopy 2005; 37: 318-323
• 24 Yano T, Yamamoto H, Sunada K et al. Endoscopic classification of vascular lesions of the small intestine (with videos). Gastrointest Endosc 2008; 67: 169-172
• 25 Hindryckx P, Botelberge T, De Vos M et al. Clinical impact of capsule endoscopy on further strategy and long-term clinical outcome in patients with obscure bleeding. Gastrointest Endosc 2008; 68: 98-104
• 26 Viazis N, Papaxoinis K, Vlachogiannakos J et al. Is there a role for second-look capsule endoscopy in patients with obscure GI bleeding after a nondiagnostic first test?. Gastrointest Endosc 2009; 69: 850-856
• 27 Richter JM, Christensen MR, Colditz GA et al. Angiodysplasia. Natural history and efficacy of therapeutic interventions. Dig Dis Sci 1989; 34: 1542-1546
• 28 Saurin JC, Delvaux M, Gaudin JL et al. Diagnostic value of endoscopic capsule in patients with obscure digestive bleeding: blinded comparison with video push-enteroscopy. Endoscopy 2003; 35: 576-584
• 29 Lai LH, Wong GL, Chow DK et al. Long-term follow-up of patients with obscure gastrointestinal bleeding after negative capsule endoscopy. Am J Gastroenterol 2006; 101: 1224-1228
• 30 Xin L, Liao Z, Jiang YP et al. Indications, detectability, positive findings, total enteroscopy, and complications of diagnostic double-balloon endoscopy: a systematic review of data over the first decade of use. Gastrointest Endosc 2011; 74: 563-570
• 31 Macdonald J, Porter V, McNamara D. Negative capsule endoscopy in patients with obscure GI bleeding predicts low rebleeding rates. Gastrointest Endosc 2008; 68: 1122-1127
• 32 Park JJ, Cheon JH, Kim HM et al. Negative capsule endoscopy without subsequent enteroscopy does not predict lower long-term rebleeding rates in patients with obscure GI bleeding. Gastrointest Endosc 2010; 71: 990-997
• 33 James MW, Chen CM, Goddard WP et al. Risk factors for gastrointestinal malignancy in patients with iron-deficiency anaemia. Eur J Gastroenterol Hepatol 2005; 17: 1197-1203